Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women between 45 and 55 years of age
- People diagnosed with breast cancer that has been confirmed by lab testing to be hormone receptor-positive (meaning the cancer cells respond to hormones)
- People who are in the perimenopausal stage, defined as having had their last period within the 3 months before enrolling, and having specific hormone levels within a set range (confirm with trial site for exact values)
- People who are planned to receive follow-up cancer treatment, either chemotherapy, hormone-blocking therapy, or both
- People who are willing to have regular blood samples taken and to keep a written diary tracking their menstrual cycle
- People who are able to give written consent to participate
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have already gone through menopause
- People who have had both ovaries surgically removed, or who have had radiation therapy to the pelvic area
- People with serious liver or kidney problems
- People whose breast cancer has tested negative for both estrogen and progesterone receptors
- People with conditions that affect how the ovaries produce hormones, such as ovarian tumours, polycystic ovary syndrome, or pituitary gland tumours
- People who are currently pregnant, breastfeeding, or planning to become pregnant during the study period
- People who are currently using a hormonal intrauterine device (a type of hormonal contraceptive fitted inside the uterus)
- People who have previously used certain hormone-related medications, specifically GnRH agonists or aromatase inhibitors
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13390127607
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Association Between Dynamic AMH Changes and Occurrence of Menopause
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.